Statement
5 Jun 2023
G20 3rd Health Working Group Meeting: Health Emergencies Prevention, Preparedness, and Response (HEPPR)
On 4 June, IFPMA delivered a statement on Priority I “Health Emergencies Prevention, Preparedness, and Response” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read more
Statement
5 Jun 2023
G20 3rd Health Working Group Meeting: Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)
On 4 June, IFPMA delivered a statement on Priority II “Strengthening cooperation in pharmaceutical sector with focus on availability and access to safe, effective, quality, and affordable medical countermeasures (MCM) – VTDs (vaccines, therapeutics, and diagnostics)” at the G20 3rd Health Working Group Meeting in Hyderabad.
Read more
Statement
30 May 2023
Innovative pharmaceutical industry contributes to discussions on universal health coverage and health security during 76th World Health Assembly
On 30 May, IFPMA issued a statement summarizing their contributions to universal health coverage and health security at the 76th World Health Assembly.
Read more